Telomerase activity in gastric cancer and its clinical implications

Table 1 Telomerase expression in gastric cancer

Groups	Telomerase activity		Positive rate(%)
	Positive	Negative
Gastric cancer (n = 94)	81	13	86.2
Normal tissue (n = 58)	0	58	0
Gastric ulcer (n = 9)	1	8	11.1
Gastric adenoma (n = 12)	1	11	8.38

Table 2 Clinical data in gastric cancer cases

Groups	Telomerase activity		χ2	P
	Positive(n = 81)	Negative(n = 13)
Tumor size (cm)
< 5 (n = 42)	35	7
5.8 (n = 32)	29	3	0.839	0.657
> 8 (n = 20)	17	3
Histological grade
Well differentiated (n = 28)	23	5
Moderately and well differentiated(n = 18)	16	2
Poorly differentiated (n = 48)	42	6	0.564	0.754
Invasion depth	1	1
T1 (n = 2)	1	1
T2 (n = 14)	12	2
T3 (n = 38)	33	5
T4 (n = 40)	35	5	0.392	0.531
Lymph node metastasis
< 3 cm (n = 38)	30	8
> 3 cm (n = 56)	51	5	2.792	0.095
TNM stage
I (n = 2)	1	1
II (n = 23)	20	3
III (n = 42)	37	5
IV (n = 27)	23	4	0.135	0.714